Active ingredient
Cyclophosphamide
87 finished FDA listings contain Cyclophosphamide as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE ANHYDROUS
- Dosage forms
- Capsule, Injection, Injection, Powder, For Solution, Injection, Powder, Lyophilized, For Solution, Injection, Solution, Injection, Solution, Concentrate, Tablet
- Routes
- Intravenous, Oral
- Manufacturers / labelers
- 26
- Strengths listed
- 1 g/2ml · 1 g/50ml · 1 g/5ml · 1000 mg/10ml · 2 g/100ml · 2 g/10ml · 2 g/4ml · 200 mg/ml · 2000 mg/20ml · 25 mg/1 · 50 mg/1 · 500 mg/2.5ml · 500 mg/25ml · 500 mg/5ml · 500 mg/ml
- Brand names in FDA listings
- Cyclophosphamide, Frindovyx
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 3002
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 012141 | BAXTER HLTHCARE | 1959-11-16 | 2 |
| ANDA 040745 | BAXTER HLTHCARE | 2008-05-21 | 21 |
| NDA 203856 | HIKMA | 2013-09-16 | 2 |
| ANDA 204555 | HENGRUI PHARMA | 2014-10-31 | 9 |
| ANDA 210046 | AMNEAL | 2018-05-25 | 3 |
| ANDA 211608 | CIPLA | 2019-01-18 | 2 |
| NDA 212501 | DR REDDYS | 2020-07-30 | 5 |
| NDA 210735 | EUGIA PHARMA SPECLTS | 2021-08-25 | 3 |
| ANDA 211757 | XGEN PHARMS | 2022-10-18 | 3 |
| ANDA 215892 | ALEMBIC | 2022-11-10 | 4 |
| NDA 210852 | AVYXA HOLDINGS | 2023-06-07 | 6 |
| NDA 217651 | BAXTER HLTHCARE CORP | 2023-06-27 | 2 |
| ANDA 214529 | SAGENT PHARMS INC | 2023-07-17 | 3 |
| NDA 217150 | SANDOZ | 2023-09-12 | 3 |
| ANDA 216783 | NEXUS | 2024-10-29 | 2 |
| ANDA 218282 | EIRGEN | 2024-12-03 | 2 |
| ANDA 218644 | EPIC PHARMA LLC | 2024-12-19 | 9 |
| ANDA 218632 | HAINAN POLY | 2024-12-26 | 6 |
Official labeling on DailyMed
- FRINDOVYX (CYCLOPHOSPHAMIDE) INJECTION [AVYXA PHARMA, LLC] · version 12 · 2026-09-07
- CYCLOPHOSPHAMIDE INJECTION [NEXUS PHARMACEUTICALS, LLC] · version 8 · 2026-09-07
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [CIVICA, INC.] · version 10 · 2026-07-03
- CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE INJECTION, SOLUTION) INJECTION [BAXTER HEALTHCARE COMPANY] · version 3 · 2026-06-01
- CYCLOPHOSPHAMIDE TABLET [BAXTER HEALTHCARE CORPORATION] · version 7 · 2026-05-28
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE COMPANY] · version 20 · 2026-05-28
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE COMPANY] · version 15 · 2026-05-28
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE COMPANY] · version 15 · 2026-05-28
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE COMPANY] · version 18 · 2026-05-28
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BLUEPOINT LABORATORIES] · version 1 · 2026-03-16
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BLUEPOINT LABORATORIES] · version 4 · 2026-02-16
- CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [AVENACY, LLC] · version 1 · 2026-02-02
Showing the 12 most recent of 31 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.